Stacey Ruiz
About
In The Last Decade
Stacey Ruiz
10 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 937
- Nephrology 463
- Endocrinology, Diabetes and Metabolism 215
- Clinical Biochemistry 180
- Pathology and Forensic Medicine 158
Countries citing papers authored by Stacey Ruiz
This map shows the geographic impact of Stacey Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Ruiz more than expected).
Fields of papers citing papers by Stacey Ruiz
This network shows the impact of papers produced by Stacey Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Ruiz. The network helps show where Stacey Ruiz may publish in the future.
Co-authorship network of co-authors of Stacey Ruiz
This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Ruiz. A scholar is included among the top collaborators of Stacey Ruiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Ruiz. Stacey Ruiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 16 | |
| 5 | Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease breakdown → | 596 |
| 6 | 55 | |
| 7 | 197 | |
| 8 | Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes breakdown → | 707 |
| 9 | 89 | |
| 10 | 1 | |
| 11 | Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. | 39 |
| 12 | 39 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.